Menin Inhibition in Acute Myeloid Leukemia: Rewiring Leukemic Transcriptional Networks. [PDF]
Tarhini A +3 more
europepmc +1 more source
A New Paradigm for Pediatric AML: Improving the Pipeline for Treatments Targeting Cytogenetic and Molecular Alterations. [PDF]
Ayerbe C +14 more
europepmc +1 more source
Menin inhibition reshapes therapy in <i>NPM1</i>-mutated acute myeloid leukemia. [PDF]
Htut TW, Yilmaz M.
europepmc +1 more source
Anti-inflammatory approaches in cancer immunotherapy-induced autoimmunity. [PDF]
Zeiser R.
europepmc +1 more source
Two Decades of <i>NPM1</i>-Mutated Acute Myeloid Leukemia: From Molecular Insights to Clinical Decision-Making. [PDF]
Cimino G +7 more
europepmc +1 more source
FLT3-mutated AML: standards of care and ongoing investigation. [PDF]
Do LV, Jorgensen JJ, Sahasrabudhe KD.
europepmc +1 more source
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia. [PDF]
Scheidegger N +22 more
europepmc +1 more source
Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.
Barajas JM +27 more
europepmc +1 more source
MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10-Mediated Angiogenesis. [PDF]
Wei C +17 more
europepmc +1 more source
Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms. [PDF]
Wen J +15 more
europepmc +1 more source

